← All trials
NCT03052179
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2017
- Primary completion
- Oct 1, 2018
- Completion date
- Jan 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- University of LondonOverall official - principal investigator
Drugs studied
- bifidobacterium infantis
- bifidobacterium infantis
- bifidobacterium breve
- bifidobacterium breve
- bifidobacterium longum
- bifidobacterium longum
- lactobacillus plantarum
- lactobacillus plantarum
- vsl #3
- vsl #3
- streptococcus salivarius
- streptococcus salivarius
- Lactobacillus acidophilus
- Lactobacillus acidophilus
- lactobacillus casei
- lactobacillus casei
- lactobacillus delbrueckii
- lactobacillus delbrueckii
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.